ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS - ORA - Oxford University Research Archive

Back to Search

- BibTeX
- EndNote
- RefWorks

Journal article

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

SNOOK, J., Chapman, R., FLEMING, K., & JEWELL, D. (1988). ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS. GUT, 29(10), A1494–A1494.

MLA Style

SNOOK, J., et al. “ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS.” GUT, vol. 29, no. 10, 1988, pp. A1494–A1494.

Chicago Style

SNOOK, J, R Chapman, K FLEMING, and D JEWELL. 1988. “ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS.” GUT 29 (10): A1494–A1494.
Tweet
Print

Authors

+ SNOOK, J More by this author

Role:

Author

+ Chapman, R More by this author

Institution:

University of Oxford

Department:

Oxford, MSD, Clinical Medicine, Experimental Medicine Division,

Role:

Author

+ FLEMING, K More by this author

Role:

Author

+ JEWELL, D More by this author

Role:

Author

Bibliographic Details

Journal:: GUT
Volume:: 29
Issue:: 10
Pages:: A1494-A1494
Publication date:: 1988-10-05
ISSN:: 0017-5749
URN:: uuid:f1df70d5-bd5b-439e-a00d-84a9b4f3b1ab
Source identifiers:: 167154
Local pid:: pubs:167154

Terms of use

Copyright date:: 1988

License:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP